STOCK TITAN

Savara Inc. (SVRA) director receives 40,000 RSUs vesting December 9, 2026

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Savara Inc. director Richard Hawkins reported an equity award of 40,000 restricted stock units (RSUs) of Savara common stock dated December 9, 2025. The RSUs vest in full on December 9, 2026, provided he continues his service with the company, and each RSU represents a right to receive one share of common stock. He has elected to defer delivery of the vested shares until after his service with Savara ends. Following this grant, he beneficially owns 161,326 shares of Savara common stock in direct ownership.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hawkins Richard J

(Last) (First) (Middle)
ONE SUMMIT SQUARE,
1717 LANGHORNE NEWTOWN ROAD, SUITE 300

(Street)
LANGHORNE PA 19047

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Savara Inc [ SVRA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/09/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/09/2025 12/09/2025 A 40,000(1) A $0.00 161,326 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units ("RSUs") that vest in full on December 9, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reporting person has elected to defer receipt of the shares of common stock underlying the RSUs upon vesting. In accordance with the reporting person's deferral election, the vested shares will be delivered to the reporting person following the reporting person's termination of service with the Issuer.
/s/ David Lowrance as attorney-in-fact for Richard Hawkins 12/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Savara (SVRA) report for December 9, 2025?

The report shows Savara director Richard Hawkins received 40,000 restricted stock units (RSUs) of Savara common stock on December 9, 2025 at a price of $0.00 per share.

When do Richard Hawkins' 40,000 Savara RSUs vest?

The 40,000 RSUs granted to Richard Hawkins vest in full on December 9, 2026, subject to his continued service with Savara through that date.

How many Savara (SVRA) shares does Richard Hawkins beneficially own after this grant?

After the reported RSU grant, Richard Hawkins beneficially owns 161,326 shares of Savara common stock in direct ownership.

What does each RSU granted to Richard Hawkins represent for Savara stock?

Each restricted stock unit granted to Richard Hawkins represents a contingent right to receive one share of Savara’s common stock upon settlement.

When will Richard Hawkins receive the Savara shares from his deferred RSUs?

Hawkins elected to defer receipt of the shares underlying the RSUs, so the vested shares will be delivered to him after his termination of service with Savara.

Was any cash paid for the 40,000 Savara RSUs granted to Richard Hawkins?

No cash changed hands for the grant itself; the transaction lists a price of $0.00 per share for the 40,000 RSUs awarded.

Savara Inc

NASDAQ:SVRA

SVRA Rankings

SVRA Latest News

SVRA Latest SEC Filings

SVRA Stock Data

1.32B
187.64M
5.38%
99.91%
9.07%
Biotechnology
Pharmaceutical Preparations
Link
United States
AUSTIN